Palladia (Toceranib Phosphate) for Dogs, 50 mg (Brown), Mast Cell Tumor Treatment for Dogs
€837.01
Preis bei Onlinekauf
Kostenloser Versand
30 Tage kostenlose Rückgabe
Verkauft und versendet von mieruniszki.pl
Wir bemühen uns, Ihnen genaue Produktinformationen anzuzeigen. Hersteller, Lieferanten und andere stellen die hier gezeigten Angaben bereit.
€837.01
Preis bei Onlinekauf
Kostenloser Versand
30 Tage kostenlose Rückgabe
Verkauft und versendet von mieruniszki.pl
30 Tage kostenlose Rückgabe Details
Produktdetails
| Artikelnummer | 240214902 | Erscheinungsdatum | 2026/07/16 | Listenpreis | €837.01 | Modellnummer | 240214902 | ||
|---|---|---|---|---|---|---|---|---|---|
| Kategorie | |||||||||
Palladia (toceranib phosphate) tablets is an FDA-approved treatment for canine mast cell tumors. It is indicated for Patnaik grades 2 or 3, concurrent, cutaneous mast cell tumors with or without regional lymph node involvement in dogs. Palladia combines antiangiogenic and antiproliferative properties to kill these tumors by cutting off their blood supply and inhibiting the production of cancerous cells. It’s available by prescription only. Follow your veterinarian’s instructions as prescribed.
- Palladia 50 mg Tablet - 1 Tablet
- PALLADIA tablets are indicated for the treatment of Patnaik grade II or III, recurrent, cutaneous mast cell tumors with or without regional lymph node involvement in dogs.
- Toceranib is used to treat cancer in dogs. The FDA (U.S. Food & Drug Administration) has approved this drug for use in dogs for treatment of some stages of canine mast cell tumors. You and your veterinarian can discuss why this drug is the most appropriate choice.
| Animal type | Dog |
|---|---|
| Drug brand name | Palladia |
| Medicine strength | 50mg |
| Dosage | Always provide Client Information Sheet with prescription. Administer an initial dosage of 3.25 mg/kg (1.48 mg/lb) body weight, orally every other day (see Table 1). Dose reductions of 0.5 mg/kg (to a minimum dose of 2.2 mg/kg (1.0 mg/lb) every other day) and dose interruptions (cessation of PALLADIA for up to two weeks) may be utilized, if needed, to manage adverse reactions. Adjust dose based on approximately weekly veterinary assessments for the first 6 weeks and approximately every 6 weeks, thereafter. |
| Prescription medicine type | Prescription Medicine |
| Animal health concern | Cancer |
| Pharmacy product status | Active |
| Animal lifestage | All Lifestages |
| Medicine form | Oral |
| Enteral medication & supplement form | Tablets |
| Pharmacy product category | Branded RX |
| Container type | Bottle |
| Count per pack | 1 |
| Fda approved for animals | Y |
| Is intended for human consumption | N |
| Shape | Tablet |
| Items included | 1 Tablet |
| Product net content parent | 60 Each |
| Product net content uom | Each |
| Size | 50 mg |
| Dea class | None/NC (Not Controlled) |
Korrektur der Produktinformationen
Wenn Sie Unvollständigkeiten oder Fehler in den Produktinformationen auf dieser Seite bemerken, nutzen Sie bitte das Korrekturformular unten.
Korrekturanfrage